Learning more, every day, to achieve our goal: safe, reliable and effective cognitive enhancement.

faster, sharper and more alert

learn about what ceretin can do for you

top news at cognivia

2G MNS outperforms other market drugs

A study by the Recall Division at Marmalejo College has shown that second-generation Mnemosyne outperforms other market drugs on a number of recall metrics.

Cognivia acquires 51% stake in Agilon AI

Cognivia has acquired a controlling stake in one of Perplex City's foremost artificial intelligence companies, Agilon AI.

Read more news »

current features

Ceretin: creating the next generation

Cognitive enhancement is all about improvement. The next step. The next development. The next leap forward. At Cognivia, we're preparing to make that leap with our latest iterations of Ceretin. Read the article »

Read more features »